drugset / Trial / NCT00005889

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

NCT00005889

Treatment

Summary

RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis is the production of sugar from amino acids and fats. The best combination of amino acids, fat, and sugar to help very low birth weigh infants maintain normal blood sugar levels is not yet known. PURPOSE: Clinical trial to study how very low birth weight infants break down amino acids, fat, and sugar given by intravenous infusion, and the effect of different combinations of nutrients on the infants' ability to maintain normal blood sugar levels.

Timeline

Start
1999-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown Intravenous
Subject Glutamine Other / unclassified Intravenous
Subject Glycerol Small molecule Intravenous
Subject alanine Unknown Intravenous
Subject amino acids Unknown Intravenous
Subject urea Unknown Intravenous
Background Glucagon Peptide Intravenous
Background Insulin Protein / enzyme biologic Intravenous

Indications